Creo Medical Group PLC (CREO) — Cash Flow-to-Debt Ratio
Creo Medical Group PLC (CREO) has a Cash Flow-to-Debt Ratio of 1.97x as of June 2025, meaning its operating cash flow of GBX15.60 Million could theoretically repay 2% of its total liabilities (GBX7.90 Million) in one year. See CREO free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Creo Medical Group PLC Cash Flow-to-Debt Ratio (2014–2024)
Historical debt coverage capacity for Creo Medical Group PLC across 13 annual periods. Also explore CREO shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Creo Medical Group PLC (2014–2024)
Year-by-year debt coverage analysis for Creo Medical Group PLC. For market capitalisation and broader financial context, see Creo Medical Group PLC (CREO) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (GBX) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.98x | GBX-22.20 Million | GBX22.60 Million | ▲ +23.6% |
| 2023 | -1.29x | GBX-21.60 Million | GBX16.80 Million | ▼ -33.4% |
| 2022 | -0.96x | GBX-24.99 Million | GBX25.93 Million | ▼ -1.2% |
| 2021 | -0.95x | GBX-25.98 Million | GBX27.29 Million | ▼ -75.5% |
| 2020 | -0.54x | GBX-16.09 Million | GBX29.66 Million | ▲ +73.7% |
| 2019 | -2.06x | GBX-11.54 Million | GBX5.60 Million | ▲ +70.5% |
| 2018 | -6.98x | GBX-14.20 Million | GBX2.03 Million | ▼ -128.6% |
| 2018 | -3.05x | GBX-7.00 Million | GBX2.29 Million | ▲ +35.0% |
| 2017 | -4.70x | GBX-6.91 Million | GBX1.47 Million | ▼ -126.0% |
| 2016 | -2.08x | GBX-1.64 Million | GBX788.81K | ▲ +64.6% |
| 2016 | -5.87x | GBX-3.13 Million | GBX532.79K | ▲ +23.7% |
| 2015 | -7.69x | GBX-2.27 Million | GBX295.98K | ▼ -41.3% |
| 2014 | -5.44x | GBX-1.36 Million | GBX250.20K | — |